Robin Feldman
Impact in
-
- Intellectual Property and Patents
- Health Informatics top 10%
Papers in
-
- Pharmaceutical Economics and Policy 29
- Health Systems, Economic Evaluations, Quality of Life 8
- Innovation Policy and R&D 7
-
- Intellectual Property and Patents 36
- Co-authors
- Mark A. Lemley (5 shared papers)Tom A. Ewing (1 shared paper)Connie W. Wang (5 shared papers)Mark J. Ratain (2 shared papers)W. Nicholson Price (2 shared papers)Daniel A. Goldstein (1 shared paper)Alec Kacew (1 shared paper)David A. Hyman (1 shared paper)
- Journals
- Journal of Law and the Biosciences (4 papers)Nature Biotechnology (3 papers)New England Journal of Medicine (2 papers)Hastings law journal (2 papers)The Georgetown law journal (1 paper)
- Partner nations
- United StatesSwedenIsrael
In The Last Decade
Robin Feldman
91 papers receiving 497 citations
Peers
Comparison fields: 5 of 102
- Management of Technology and Innovation 191
- Health Informatics 15
- Economics and Econometrics 250
- Pharmacology 45
- Business and International Management 9
Countries citing papers authored by Robin Feldman
This map shows the geographic impact of Robin Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Feldman more than expected).
Fields of papers citing papers by Robin Feldman
This network shows the impact of papers produced by Robin Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Feldman. The network helps show where Robin Feldman may publish in the future.
Co-authors
The 15 scholars most cited alongside Robin Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 63 | |
| 2 | 2018 | 59 | |
| 3 | 2016 | 32 | |
| 4 | Artificial Intelligence in the Health care Space: How We Can Trust What We Cannot Know | 2019 | 23 |
| 5 | 2011 | 21 | |
| 6 | 2015 | 21 | |
| 7 | 2004 | 16 | |
| 8 | A Neurological Foundation for Freedom | 2012 | 15 |
| 9 | 2004 | 14 | |
| 10 | 2013 | 13 | |
| 11 | Patent Demands & Startup Companies The View from the Venture Capital Community | 2014 | 11 |
| 12 | Do Patent Licensing Demands Mean Innovation | 2015 | 11 |
| 13 | 2012 | 11 | |
| 14 | 2017 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2021 | 9 | |
| 17 | Understanding and Incentivizing Biosimilars | 2012 | 9 |
| 18 | 2021 | 8 | |
| 19 | Plain Language Patents | 2008 | 8 |
| 20 | The America Invents Act 500: Effects of Patent Monetization Entities on US Litigation | 2012 | 7 |
About Robin Feldman
Robin Feldman is a scholar working on Economics and Econometrics, Management of Technology and Innovation, Artificial Intelligence, Pharmacology and Physiology, having authored 99 papers that have together received 554 indexed citations. Recurring topics across this work include Intellectual Property and Patents (36 papers), Pharmaceutical Economics and Policy (29 papers), Pharmaceutical industry and healthcare (16 papers), Law, AI, and Intellectual Property (16 papers), Biomedical Ethics and Regulation (15 papers), Private Equity and Venture Capital (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Innovation Policy and R&D (7 papers). The work is most often cited by research in Management of Technology and Innovation (191 citations), Health Informatics (15 citations), Economics and Econometrics (250 citations), Pharmacology (45 citations) and Business and International Management (9 citations). Robin Feldman has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Mark A. Lemley, Tom A. Ewing, Connie W. Wang, Mark J. Ratain, W. Nicholson Price, Daniel A. Goldstein, Alec Kacew, David A. Hyman, Garth W. Strohbehn and Gerard F. Anderson. Their work appears in journals such as Journal of Law and the Biosciences, Nature Biotechnology, New England Journal of Medicine, Hastings law journal and The Georgetown law journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.